Inactive Instrument

News ROCE BAY Other OTC

Equities

End-of-day quote Other OTC Other stock markets
- ^USD	-

2009	ROCHE BAY PLC : Roche drug Avastin fails cancer study, shares fall	RE
2009	ROCHE BAY PLC : Roche beats recession in first quarter	RE

ROCHE BAY PLC : Roche drug Avastin fails cancer study, shares fall	09-04-22	RE
ROCHE BAY PLC : Roche beats recession in first quarter	09-04-16	RE
ROCHE BAY PLC : Roche confident for full year after Q1 sales rise	09-04-16	RE
ROCHE BAY PLC : Roche Q1 sales rise 8 percent	09-04-16	RE
ROCHE BAY PLC : Roche Q1 sales rise 8 percent, confident on FY goals	09-04-16	RE
ROCHE BAY PLC : Roche secures 96 percent of Genentech, plans to delist	09-03-26	RE
ROCHE BAY PLC : Roche controls 96.2 percent of Genentech as bid closes	09-03-26	RE
ROCHE BAY PLC : Roche's $46.8 billion Genentech deal outshines others	09-03-12	RE
ROCHE BAY PLC : Roche wins Genentech with raised $46.8 billion offer	09-03-12	RE
ROCHE BAY PLC : Roche agrees to buy Genentech for $46.8 billion	09-03-12	RE
ROCHE BAY PLC : Roche says latest Genentech bid is still fair	09-03-10	RE
ROCHE BAY PLC : Roche, Genentech in talks on $47 billion deal	09-03-09	RE
ROCHE BAY PLC : Roche, Genentech in talks for $95/shr deal	09-03-09	RE
ROCHE BAY PLC : Roche, Genentech in talks for $95 a share deal	09-03-09	RE
ROCHE BAY PLC : Roche seen sealing Genentech deal after upping bid	09-03-09	RE
ROCHE BAY PLC : Roche increases Genentech offer to $45.7 billion	09-03-06	RE
ROCHE BAY PLC : Roche ups Genentech bid to $45.7 billion	09-03-06	RE
ROCHE BAY PLC : Roche seen upping $42 billion Genentech bid after rebuff	09-02-24	RE
ROCHE BAY PLC : Roche sees slower growth but confident on Genentech	09-02-04	RE
ROCHE BAY PLC : Roche sees slower growth as profit drops 5 percent	09-02-04	RE

No results for this search